Functional Characterization of Two Novel Mutations in


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jun 2021
Historique:
received: 12 05 2021
revised: 11 06 2021
accepted: 14 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 17 7 2021
Statut: epublish

Résumé

Brugada syndrome (BrS) is an autosomal dominantly inherited cardiac disease characterized by "coved type" ST-segment elevation in the right precordial leads, high susceptibility to ventricular arrhythmia and a family history of sudden cardiac death. The Here, we describe the clinical findings of two Italian families affected by BrS and provide the functional characterization of two novel Despite being clinically different, both patients have a family history of sudden cardiac death and had history of arrhythmic events. The Pro1310Leu mutation significantly reduced peak sodium current density without affecting channel membrane localization. Changes in the gating properties of expressed Pro1310Leu channel likely account for the loss-of-function phenotype. On the other hand, Gly1687_Ile1688insGlyArg channel, identified in a female patient, yielded a nearly undetectable sodium current. Following mexiletine incubation, the Gly1687_Ile1688insGlyArg channel showed detectable, albeit very small, currents and biophysical properties similar to those of the Nav1.5 wild-type channel. Overall, our results suggest that the degree of loss-of-function shown by the two Nav1.5 mutant channels correlates with the aggressive clinical phenotype of the two probands. This genotype-phenotype correlation is fundamental to set out appropriate therapeutical intervention.

Sections du résumé

BACKGROUND BACKGROUND
Brugada syndrome (BrS) is an autosomal dominantly inherited cardiac disease characterized by "coved type" ST-segment elevation in the right precordial leads, high susceptibility to ventricular arrhythmia and a family history of sudden cardiac death. The
METHODS METHODS
Here, we describe the clinical findings of two Italian families affected by BrS and provide the functional characterization of two novel
RESULTS RESULTS
Despite being clinically different, both patients have a family history of sudden cardiac death and had history of arrhythmic events. The Pro1310Leu mutation significantly reduced peak sodium current density without affecting channel membrane localization. Changes in the gating properties of expressed Pro1310Leu channel likely account for the loss-of-function phenotype. On the other hand, Gly1687_Ile1688insGlyArg channel, identified in a female patient, yielded a nearly undetectable sodium current. Following mexiletine incubation, the Gly1687_Ile1688insGlyArg channel showed detectable, albeit very small, currents and biophysical properties similar to those of the Nav1.5 wild-type channel.
CONCLUSIONS CONCLUSIONS
Overall, our results suggest that the degree of loss-of-function shown by the two Nav1.5 mutant channels correlates with the aggressive clinical phenotype of the two probands. This genotype-phenotype correlation is fundamental to set out appropriate therapeutical intervention.

Identifiants

pubmed: 34204499
pii: ijms22126513
doi: 10.3390/ijms22126513
pmc: PMC8234720
pii:
doi:

Substances chimiques

NAV1.5 Voltage-Gated Sodium Channel 0
SCN5A protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN 2017
Organisme : Universita degli Studi di Bari Aldo Moro
ID : Fondi Ateneo 2017-2018

Références

J Am Coll Cardiol. 2018 Aug 28;72(9):1046-1059
pubmed: 30139433
Int J Cardiol. 2018 Sep 1;266:128-132
pubmed: 29709244
Nat Commun. 2017 Dec 12;8(1):2077
pubmed: 29233994
Pharmacol Res. 2019 Mar;141:224-235
pubmed: 30611854
Heart Rhythm. 2013 Feb;10(2):264-72
pubmed: 23085483
J Cardiovasc Electrophysiol. 2009 Oct;20(10):1137-41
pubmed: 19549036
Int J Mol Sci. 2018 Feb 28;19(3):
pubmed: 29495624
J Cardiovasc Electrophysiol. 2019 Jan;30(1):128-131
pubmed: 30375078
Eur Heart J. 2021 Mar 14;42(11):1082-1090
pubmed: 33221895
Eur Heart J Suppl. 2020 Jun;22(Suppl E):E101-E104
pubmed: 32523450
Front Cardiovasc Med. 2021 Apr 21;8:652027
pubmed: 33969014
J Biomed Sci. 2017 Dec 4;24(1):91
pubmed: 29202755
Cardiovasc Res. 2004 Apr 1;62(1):53-62
pubmed: 15023552
Circ Res. 2015 Jun 5;116(12):1971-88
pubmed: 26044251
Heart Rhythm. 2009 Mar;6(3):341-8
pubmed: 19251209
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
J Mol Cell Cardiol. 2016 Mar;92:52-62
pubmed: 26801742
Eur Heart J Suppl. 2019 Mar;21(Suppl B):B61-B66
pubmed: 30948952
Eur Heart J. 2018 Nov 21;39(44):3925-3931
pubmed: 30215713
Curr Probl Cardiol. 2016 Jan;41(1):7-57
pubmed: 26671757
J Cardiovasc Electrophysiol. 2019 Jan;30(1):118-127
pubmed: 30203441
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Curr Probl Cardiol. 2021 Mar;46(3):100454
pubmed: 31522883
Circulation. 2019 Aug 13;140(7):595-610
pubmed: 31403841
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1250-H1257
pubmed: 30118344
JACC Clin Electrophysiol. 2018 May;4(5):569-579
pubmed: 29798782
Cell. 2020 Jan 9;180(1):122-134.e10
pubmed: 31866066
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1822-8
pubmed: 16632547
Heart Rhythm. 2020 May;17(5 Pt A):743-749
pubmed: 31790831
Card Electrophysiol Clin. 2017 Dec;9(4):537-549
pubmed: 29173400
Circulation. 2017 Jun 6;135(23):2255-2270
pubmed: 28341781
Cardiovasc Res. 2020 Jul 15;116(9):1557-1570
pubmed: 32251506
Clin Genet. 2020 Jan;97(1):198-208
pubmed: 30963536
Int J Cardiol. 2018 Mar 1;254:151-156
pubmed: 29224924
Can J Cardiol. 2014 Jul;30(7):783-92
pubmed: 24970790
Cardiology. 2017;137(4):256-260
pubmed: 28494446
Hum Mutat. 2019 Jun;40(6):749-764
pubmed: 30821013
Front Pharmacol. 2016 May 10;7:121
pubmed: 27242528
Cardiovasc Res. 2012 Jan 1;93(1):12-23
pubmed: 21937582
Heart Rhythm. 2004 Nov;1(5):600-7
pubmed: 15851227
Nat Rev Cardiol. 2016 Dec;13(12):744-756
pubmed: 27629507
Heart Rhythm. 2010 Jan;7(1):33-46
pubmed: 20129283
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:133-154
pubmed: 31537174
J Am Coll Cardiol. 2018 Dec 4;72(22):2758-2760
pubmed: 30497562
Pacing Clin Electrophysiol. 2017 Jun;40(6):703-712
pubmed: 28370132

Auteurs

Cristina Balla (C)

Cardiological Center, University of Ferrara, 44121 Ferrara, Italy.

Elena Conte (E)

Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Rita Selvatici (R)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Renè Massimiliano Marsano (RM)

Department of Biology, University of Bari "Aldo Moro", 70125 Bari, Italy.

Andrea Gerbino (A)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", 70125 Bari, Italy.

Marianna Farnè (M)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Rikard Blunck (R)

Department of Physics, Université de Montréal, Montréal, QC H3C 3J7, Canada.

Francesco Vitali (F)

Cardiological Center, University of Ferrara, 44121 Ferrara, Italy.

Annarita Armaroli (A)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Alessandro Brieda (A)

Cardiological Center, University of Ferrara, 44121 Ferrara, Italy.

Antonella Liantonio (A)

Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Annamaria De Luca (A)

Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Alessandra Ferlini (A)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Claudio Rapezzi (C)

Cardiological Center, University of Ferrara, 44121 Ferrara, Italy.
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Italy.

Matteo Bertini (M)

Cardiological Center, University of Ferrara, 44121 Ferrara, Italy.

Francesca Gualandi (F)

Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Paola Imbrici (P)

Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH